[Pharmacological studies on diuretics. 7. Diuretic activity and mechanism of action of a new thiazide diuretic, penfluzide].
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000471:Alkalosis / Q000503:physiopathology; D000818:Animals; D000959:Antihypertensive Agents; D001539:Bendroflumethiazide / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D003499:Cyclic S-Oxides / Q000494:pharmacology; D004231:Diuresis; D004232:Diuretics; D004285:Dogs; D004573:Electrolytes / Q000652:urine; D004976:Ethacrynic Acid / Q000494:pharmacology; D005919:Glomerular Filtration Rate; D006857:Hydroflumethiazide / Q000494:pharmacology; D006973:Hypertension / Q000503:physiopathology; D007671:Kidney Concentrating Ability; D007684:Kidney Tubules / Q000503:physiopathology; D009393:Nephritis / Q000503:physiopathology; D051381:Rats; D049993:Sodium Chloride Symporter Inhibitors / Q000494:pharmacology*; D013449:Sulfonamides / Q000494:pharmacology
D000959:Antihypertensive Agents; D003499:Cyclic S-Oxides; D004232:Diuretics; D004573:Electrolytes; D049993:Sodium Chloride Symporter Inhibitors; D013449:Sulfonamides; D006857:Hydroflumethiazide; D001539:Bendroflumethiazide; D000251:Adenosine Triphosphatases; D004976:Ethacrynic Acid